Review of Evidence-based Support for Pretreatment Imaging in Melanoma

Article

This online activity provides oncology professionals a review of diagnosing and treating patients with melanoma.

Credits: 0.75

Fee: None

Expiration: April 15, 2010

Multimedia: None

Upon completing this activity, participants will be able to identify prognostic factors in patients with newly diagnosed melanoma; define the recommendations for pretreatment imaging from the National Comprehensive Cancer Network (NCCN) in patients with melanoma; describe the types of pretreatment imaging techniques used in patients with melanoma; describe imaging techniques for identifying regional lymph node metastases in patients with newly diagnosed melanoma; and describe biochemical tests used for assessing prognosis in patients with melanoma.

Click here to access this thrid-party website.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
A panel of 5 experts on iron deficiency anemia
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Phase 2 Data Shows KP1077 Meaningfully Improves Idiopathic Hypersomnia Symptoms
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
© 2024 MJH Life Sciences

All rights reserved.